High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma

NCT00965289 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

B-Cell Lymphoma

Interventions

DRUG: Rituximab

Sponsor

Nantes University Hospital

Collaborators

[object Object]
[object Object]